News for Aytu BioScience (AYTUZ)

AI sentiment analysis for trading uses AI to read market sentiment from news and social media. Traders can predict market movements and plan their trades

Aytu BioScience stock hits 52-week low at $2.2 amid market challenges

Earnings call: Aytu BioPharma reports turnaround with focus on ADHD

Aytu BioScience (AYTU) to report Q4 earnings on Sep. 26th.

Laurel Lee from Florida's 15th district invests in TuHURA Biosciences

Earnings call: Aytu BioPharma sees revenue growth, shifts focus to ADHD

The Global Male Infertility Market Size was Valued at USD 3.79 Billion in 2023 and the Worldwide Male Infertility Market Size is Expected to Reach USD 5.34...

Earnings call: Aytu BioPharma achieves first positive operating income

Improve Patients Respiratory Conditions and Reduce Irritation during Throat Infection. US anticipates 4.80% CAGR, driven by seasonal cough and cold issues,...

Aytu BioScience beats expectations with record revenues and prescriptions, reporting a Q4 GAAP EPS of -$0.59 and revenue of $30.73M (+11.9% Y/Y).

Press release Cambridge, MA U.S.A. — Allarity Therapeutics, Inc. , a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP®... | September 26, 2022

Read Investment Analysts’ Updated EPS Estimates for May 19th (ATLC, ATNM, AUTL, AXON, AYTU, BBLN, BEKE, BHB, BIVI, BOLT) at ETF Daily News

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...

Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly ...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A acti...

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO ...

NEW YORK, Jan. 30, 2021 /PRNewswire/ --?Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: ... | January 31, 2021

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: CounterPath Corporation (NASDAQ: CPAH)...

NEW YORK, Jan. 30, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: